GENFIT
GENFIT, a biopharmaceutical company headquartered in France, is at the forefront of developing innovative therapies for metabolic and liver diseases. Founded in 2008, the company has made significant strides in the industry, particularly with its focus on non-alcoholic steatohepatitis (NASH) and other related conditions. With a robust pipeline of clinical programmes, GENFIT's core products, including its lead candidate elafibranor, are designed to address unmet medical needs in liver health. The company distinguishes itself through its commitment to precision medicine and the integration of advanced biomarkers in its research. Recognised for its expertise, GENFIT has established a strong market position, contributing to the evolving landscape of liver disease treatment. Its dedication to innovation and patient-centric solutions continues to drive its success in the biopharmaceutical sector.
DitchCarbon Score
How does GENFIT's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GENFIT's score of 47 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GENFIT's reported carbon emissions
In 2023, GENFIT reported total carbon emissions of approximately 756,000 kg CO2e, comprising 663,000 kg CO2e from Scope 1 and 92,000 kg CO2e from Scope 2 emissions. The company has demonstrated a commitment to reducing its carbon footprint, with a target to decrease Scope 1 and Scope 2 emissions by 45% by 2030, using 2021 as the baseline year. In 2022, GENFIT's total emissions were about 801,000 kg CO2e, with Scope 1 emissions at 700,000 kg CO2e and Scope 2 emissions at 101,000 kg CO2e. The previous year, 2021, saw total emissions of approximately 846,000 kg CO2e, including 746,000 kg CO2e from Scope 1 and 100,000 kg CO2e from Scope 2, alongside 751,000 kg CO2e from Scope 3 emissions. GENFIT aims to achieve near-zero emissions for both Scope 1 and Scope 2 by the middle of this decade, with specific initiatives to eliminate between 300 and 350 GB of data by the end of 2024. This strategic approach reflects GENFIT's commitment to sustainability and its proactive stance in addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 627,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 110,000 | 000,000 | 000,000 | 00,000 |
| Scope 3 | - | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GENFIT is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
